References
Viskin, S., Zeltser, D., Ish-Shalom, M., et al. (2004). Is idiopathic ventricular fibrillation a short QT syndrome? Comparison of the QT intervals of patients with idiopathic ventricular fibrillation and healthy controls. Heart Rhythm, 1, 587–591.
Watanabe, H., Makiyama, T., Koyama, T., et al. (2010). High prevalence of early repolarization in short QT syndrome. Heart Rhythm, 7, 647–652.
Wolpert, C., Schimpf, R., Giustetto, C., et al. (2005). Further insights into the effect of quinidine in shortQT syndrome caused by a mutation in HERG. Journal of Cardiovascular Electrophysiology, 16, 54–58.
Vincent, G., Timothy, K., Leppart, M., et al. (1992). The spectrum of symptoms and QT intervals in carriers of the gene for the long QT syndrome. The New England Journal of Medicine, 327, 846–852.
Funada, A., Hayashi, K., Ino, H., et al. (2008). Assessment of QT intervals and prevalence of short QT syndrome in Japan. Clinical Cardiology, 31(6), 270–274.
Gallagher, M., Magliano, G., Yap, Y., et al. (2006). Distribution and prognostic significance of QT intervals in the lowest half centile in 12,012 apparently healthy persons. American Journal of Cardiology, 98(7), 933–935.
Kobza, R., Roos, M., Niggli, B., et al. (2009). Prevalence of long and short QT in a young population of 41,767 predominantly male Swiss conscripts. Heart Rhythm, 6, 652–657.
Maury, P., Extramiana, F., Spragia, P., et al. (2008). Short QT syndrome: update on a recent entity. Archives of Cardiovascular Diseases, 101, 779–786.
Schimpf, R., Wolpert, C., Gaita, F., et al. (2005). Short QT syndrome. Cardiovascular Research, 67, 357–366.
Giustetto, C., Di Monte, F., Wolpert, C., et al. (2006). Short QT syndrome: clinical findings and diagnostic-therapeutic implications. European Heart Journal, 27, 2440–2447.
Gaita, F., Giustetto, C., Bianchi, F., et al. (2003). Short QT syndrome: a familial cause of sudden death. Circulation, 108, 965–970.
Brugada, R., Hong, K., Dumaine, R., et al. (2004). Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation, 109, 30–35.
Grunnet, M., Diness, T., Hansen, R., et al. (2008). Biophysical characterization of the short QT mutation in hERG-N588K reveals a mixed gain- and loss-of-function. Cellular Physiology and Biochemistry, 22, 611–624.
Patel, C., & Antzelevitch, C. (2008). Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome. Heart Rhythm, 5, 585–590.
Bellocq, C., van Ginneken, A., Bezzina, C., et al. (2004). Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation, 109, 2394–2397.
Priori, S., Pandit, S., Rivolta, I., et al. (2005). A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circulation Research, 96(7), 800–807.
Wilde, A., & Tan, H. (2009). Inheritable potassium channel diseases. In D. Zipes & J. Jalife (Eds.), Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: Saunders.
Antzelevich, C., Pollevick, G., Cordeiro, J., et al. (2007). Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation, 115, 442–449.
Bowes, N. E., Bowes, K. R., & Towbin, J. A. (2000). The ‘final common pathway hypothesis’ and inherited cardiovascular disease. Herz, 25(3), 168–175.
Antzelevich, C. (2007). Heterogeneity and cardiac arrhythmias: an overview. Heart Rhythm, 4, 964–972.
Schimpf, R., Wolpert, C., Bianchi, F., et al. (2003). Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery. Journal of Cardiovascular Electrophysiology, 14, 1273–1277.
Antzelevitch, C. (2007). Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. AJP: Heart and Circulatory Physiology, 293, H2024–H2038.
van Houzen, N., Alshiekh-Ali, A., Garlitski, A., et al. (2008). Short QT syndrome review. Journal of Interventional Cardiac Electrophysiology, 23, 1–5.
Gaita, F., Giustetto, C., Bianchi, F., et al. (2004). Short QT syndrome: pharmacological treatment. Journal of the American College of Cardiology, 43, 1494–1499.
Mizobuchi, M., Enjoji, Y., Yamamoto, R., et al. (2008). Nifekalant and disopyramide in a patient with shortQT syndrome: evaluation of pharmacological effects and electrophysiological properties. PACE, 31, 1229–1232.
Gussak, I., Brugada, P., Brugada, J., et al. (2000). Idiopathic short QT interval: a new clinical syndrome? Cardiology, 94(2), 99–102.
Marbán, E. (2002). Cardiac channelopathies. Nature, 415, 213–218.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cross, B., Homoud, M., Link, M. et al. The short QT syndrome. J Interv Card Electrophysiol 31, 25–31 (2011). https://doi.org/10.1007/s10840-011-9566-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-011-9566-0